Edaravone in ALS.
作者信息
Takahashi Ryosuke
机构信息
Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto 606-8507, Japan.
出版信息
Exp Neurol. 2009 Jun;217(2):235-6. doi: 10.1016/j.expneurol.2009.03.001. Epub 2009 Mar 10.
Abstract
摘要
相似文献
1
Edaravone in ALS.依达拉奉治疗肌萎缩侧索硬化症
Exp Neurol. 2009 Jun;217(2):235-6. doi: 10.1016/j.expneurol.2009.03.001. Epub 2009 Mar 10.
2
Drug therapy: On the treatment trail for ALS.药物治疗：肌萎缩侧索硬化症的治疗探索
Nature. 2017 Oct 18;550(7676):S120-S121. doi: 10.1038/550S120a.
3
Edaravone (Radicava) for ALS.依达拉奉（瑞必乐）用于治疗肌萎缩侧索硬化症。
Med Lett Drugs Ther. 2017 Nov 6;59(1533):180-182.
4
Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavenger.SOD 转基因大鼠（H46R）功能测试组合的可行性研究及自由基清除剂依达拉奉的评价。
Brain Res. 2011 Mar 25;1382:321-5. doi: 10.1016/j.brainres.2011.01.058. Epub 2011 Jan 26.
5
Edaravone and its clinical development for amyotrophic lateral sclerosis.依达拉奉及其在肌萎缩侧索硬化症中的临床开发。
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):5-10. doi: 10.1080/21678421.2017.1353101.
6
Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?促红细胞生成素是肌萎缩侧索硬化症的一种潜在治疗方法吗？
Exp Neurol. 2007 Jul;206(1):11-5. doi: 10.1016/j.expneurol.2007.04.001. Epub 2007 Apr 11.
7
Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.同时阻断自由基和微粒体前列腺素 E 合酶-1 介导的 PGE2 产生可改善肌萎缩侧索硬化症小鼠模型的安全性和疗效。
J Neurochem. 2012 Sep;122(5):952-61. doi: 10.1111/j.1471-4159.2012.07771.x. Epub 2012 May 23.
8
Edaravone: a new hope for deadly amyotrophic lateral sclerosis.依达拉奉：治疗致命性肌萎缩侧索硬化症的新希望。
Drugs Today (Barc). 2018 Jun;54(6):349-360. doi: 10.1358/dot.2018.54.6.2828189.
9
Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.由限制性表达的超氧化物歧化酶cDNA引起的麻痹性疾病和蛋白质聚集的突变蛋白重合阈值。
Neurobiol Dis. 2005 Dec;20(3):943-52. doi: 10.1016/j.nbd.2005.06.005. Epub 2005 Jul 19.
10
Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.肌萎缩侧索硬化症患者氧化应激增加及依达拉奉给药的影响。
Redox Rep. 2016 May;21(3):104-12. doi: 10.1179/1351000215Y.0000000026. Epub 2016 Feb 25.
引用本文的文献
1
Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.依达拉奉对大鼠实验性青光眼模型的神经保护作用：免疫荧光和生化分析
Int J Ophthalmol. 2015 Apr 18;8(2):239-44. doi: 10.3980/j.issn.2222-3959.2015.02.05. eCollection 2015.
2
Effects of edaravone on amyloid-β precursor protein processing in SY5Y-APP695 cells.依达拉奉对 SY5Y-APP695 细胞中淀粉样前体蛋白加工的影响。
Neurotox Res. 2013 Aug;24(2):139-47. doi: 10.1007/s12640-012-9370-3. Epub 2013 Jan 17.
3
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.依达拉奉在不涉及脑梗死的神经系统疾病中神经保护作用的潜力。
Exp Ther Med. 2011 Sep;2(5):771-775. doi: 10.3892/etm.2011.281. Epub 2011 Jun 7.
Zotero 插件